LEGN - Wall Street Estimates - Legend Biotech Corporation

Healthcare - Biotechnology - NASDAQ - US

$ 32.66

3.91 %

$ 5.99 B

Market Cap

-17.01

P/E

Price Target Average

156.96%

Revenue Forecast Estimate

109.24%

EBIT Estimate

--81.14%

Net Income Estimate

39.60%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Legend Biotech Corporation

Wall Street analysts predict an average 1-year price target for LEGN of $83.9 , with forecasts ranging from a low of $60 to a high of $94 .

LEGN Lowest Price Target Wall Street Target

60 USD 83.71%

LEGN Average Price Target Wall Street Target

83.9 USD 156.96%

LEGN Highest Price Target Wall Street Target

94 USD 187.81%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free